Truncated rotavirus VP4 protein and application thereof
US11339194B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jun 15, 2020 |
| Grant date | May 24, 2022 |
| Priority date | — |
| Expiry date | Jan 27, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2720/12351
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a truncated rotavirus VP4 protein, a sequence encoding the same, a method for preparing the same, and a pharmaceutical composition and a vaccine comprising the protein, wherein the protein, the pharmaceutical composition and the vaccine are useful for preventing, alleviating or treating rotavirus infection and a disease caused by rotavirus infection, such as rotavirus gastroenteritis and diarrhea. The invention further relates to use of the protein in the manufacture of a pharmaceutical composition or a vaccine for preventing, alleviating or treating rotavirus infection and a disease caused by rotavirus infection, such as rotavirus gastroenteritis and diarrhea.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.